Mirae Asset Global ETFs Holdings Portfolio holdings
AUM
$51.7B
This Quarter Return
+6.44%
1 Year Return
+33.71%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$47.3B
AUM Growth
+$47.3B
(+6.3%)
Cap. Flow
+$1.78B
Cap. Flow
% of AUM
3.77%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,120
New
53
Increased
2,426
Reduced
560
Closed
65
Top Buys
| 1 |
Mercado Libre
MELI
|
$91.6M |
| 2 |
Palantir
PLTR
|
$91.2M |
| 3 |
Microsoft
MSFT
|
$68.1M |
| 4 |
RSSL
Global X Russell 2000 ETF
RSSL
|
$63.9M |
| 5 |
OR Royalties Inc.
OR
|
$60.4M |
Top Sells
| 1 |
Broadcom
AVGO
|
$206M |
| 2 |
Tesla
TSLA
|
$149M |
| 3 |
Meta Platforms (Facebook)
META
|
$124M |
| 4 |
BlackBerry
BB
|
$44.6M |
| 5 |
NEE.PRR
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
|
$37.9M |
Sector Composition
| 1 | Technology | 26.8% |
| 2 | Industrials | 18.74% |
| 3 | Energy | 13.56% |
| 4 | Materials | 8.39% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Transcontinental Realty Investors
TCI
$397M
| $21.4K | ﹤0.01% |
717
| – | – |
|
3002
NewMarket
NEU
$7.62B
| $20.6K | ﹤0.01% |
39
-465
| -92% | -$246K |
|
3003
Gerdau
GGB
$6.05B
| $20.5K | ﹤0.01% |
7,131
-409
| -5% | -$1.18K |
|
|
JBIO
3004
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $20.5K | ﹤0.01% |
7,742
+304
| +4% | +$743 |
|
3005
Invivyd
IVVD
$218M
| $20.5K | ﹤0.01% |
46,281
+1,976
| +4% | +$876 |
|
|
GTM
3006
ZoomInfo Technologies
GTM
$3.31B
| $19.3K | ﹤0.01% |
1,832
+419
| +30% | +$4.4K |
|
3007
Amkor Technology
AMKR
$5.88B
| $19K | ﹤0.01% |
741
-4,535
| -86% | -$117K |
|
3008
CAMP4 Therapeutics Corporation Common Stock
CAMP
$28.4M
| $18.9K | ﹤0.01% |
+3,630
| New | +$18.9K |
|
3009
Southland Holdings
SLND
$216M
| $18.8K | ﹤0.01% |
5,790
+228
| +4% | +$741 |
|
3010
RingCentral
RNG
$2.74B
| $18.4K | ﹤0.01% |
525
+49
| +10% | +$1.72K |
|
|
SBDS
3011
Solo Brands, Inc.
SBDS
$17.3M
| $18.4K | ﹤0.01% |
16,099
+5,690
| +55% | +$6.49K |
|
3012
Offerpad Solutions
OPAD
$152M
| $17K | ﹤0.01% |
5,958
+228
| +4% | +$650 |
|
3013
Solidion Technology
STI
$19.4M
| $16.9K | ﹤0.01% |
24,252
+23,751
| +4,741% | +$16.5K |
|
3014
Outlook Therapeutics
OTLK
$39.5M
| $16.4K | ﹤0.01% |
8,666
+380
| +5% | +$718 |
|
|
ELEV
3015
DELISTED
Elevation Oncology
ELEV
| $15.8K | ﹤0.01% |
28,029
+1,341
| +5% | +$754 |
|
3016
Laird Superfood
LSF
$61.5M
| $15.5K | ﹤0.01% |
+1,972
| New | +$15.5K |
|
3017
Galectin Therapeutics
GALT
$288M
| $15.1K | ﹤0.01% |
11,705
+532
| +5% | +$686 |
|
3018
TPG
TPG
$8.58B
| $14.2K | ﹤0.01% |
+226
| New | +$14.2K |
|
3019
Tevogen Bio Holdings
TVGN
$175M
| $14K | ﹤0.01% |
13,568
+532
| +4% | +$548 |
|
3020
MSC Industrial Direct
MSM
$5.03B
| $13.7K | ﹤0.01% |
184
-3
| -2% | -$224 |
|
3021
Envista
NVST
$3.37B
| $13.3K | ﹤0.01% |
692
+50
| +8% | +$965 |
|
3022
American Realty Investors
ARL
$251M
| $12.8K | ﹤0.01% |
873
| – | – |
|
3023
United Homes Group
UHG
$238M
| $12.8K | ﹤0.01% |
3,018
+152
| +5% | +$643 |
|
3024
MarketWise
MKTW
$48.6M
| $12.6K | ﹤0.01% |
22,159
+3,718
| +20% | +$2.11K |
|
3025
System1
SST
$57.2M
| $12K | ﹤0.01% |
13,411
+608
| +5% | +$548 |
|